Introduction
Nocardia is a common opportunistic pathogen; over 90 Nocardia spp. have been identified to date, of which more than 30 are human pathogens (1) (2) (3) (4) . Nocardia infections are commonly observed in individuals who undergo bone marrow or solid organ transplantation, patients on longterm steroid therapy, and patients with malignancies (5) .
Nocardiosis usually manifests in the pulmonary system, the central nervous system (CNS), or the subcutaneous tissue (6) (7) (8) . Pulmonary nocardiosis is the most common clinical manifestation and is mainly acquired through inhalation of the organism from environment. Especially in an immunocompromised host, the infection may then spread to involve the brain, eye, bone, joints, heart, kidneys, skin, or other organs and tissues (9) . A quick diagnosis has usually been hampered owing to the biological characteristics of Nocardia brasiliensis and the lack of specificity in clinical manifestations. Nocardia infections are often misdiagnosed as actinomycosis or Mycobacterium or Cryptococcus infections, delaying diagnosis and leading to the institution of inappropriate therapy, which may influence the patient outcome.
In recent years, many researchers have focused on Nocardia infections in immunocompromised hosts as this organism is reemerging as an important opportunistic pathogen (10) . Only a few cases of Nocardia infection in hosts with normal immune function have been reported, indicating a lack of systematic research on Nocardia infections in the Yantai area. Thus, we conducted a 7-year retrospective systematic retrospective study, and we hope that our findings can spread awareness about Nocardia infections.
Materials and methods

Design
This is a retrospective study of patients with nocardiosis managed at our hospital between January 2010 and December 2016. Ethical approval was provided by the Human Research Ethics Committee of our hospital.
Patients
All patients with clinically significant symptoms and culture-positive Nocardia infection was identified, and 32 patients diagnosed between January 2010 and December 2016 were eligible. Potential cases were identified through the microbiology isolate database and hospital discharge summary coding data. All cases were reviewed by at least 2 experienced investigators.
Data collection
Data on demographics, comorbidities, clinical manifestations, immunosuppressive agent and glucocorticoid administration, treatments, and outcomes were obtained from medical records. Microbiological data (specimen type, Nocardia species, and antimicrobial susceptibility) were obtained from the laboratory database.
Nocardia identification
Samples were inoculated on a blood agar plate. Dry colonies of white, light yellow, or orange color embedded in the plate and having an earthy smell as observed after 24-72 h of culture were highly suggestive of Nocardia. Colonies were subjected to Gram stain and acid-fast stain. The presence of Nocardia was confirmed on microscopic observation of small gram-positive branched bacilli with weakly positive acid-fast stain observed under microscope. Nocardia spp. were identified following the novel method described in 2016 (11) . Antimicrobial susceptibility testing was performed using the Clinical and Laboratory Standards Institute (CLSI) standardized broth microdilution method (12).
Results
Patient demographics
Between January 2010 and December 2016, 32 patients were diagnosed with Nocardia infection and their demographic characteristics are described in Table 1 . The median patient age was 48 years (range: 18-84), and 12 patients (37.5%) were male and 20 patients (62.5%) were female; furthermore, 9 patients (28.1%) were immunocompetent. The most frequently identified predisposing factor to Nocardia infection was chronic lung disease (present in 5 patients [15.6%]), primarily related to chronic obstructive pulmonary disease. The most common immunocompromising factors identified were immunosuppressive drug therapy, especially corticosteroid-based therapy.
Clinical characteristics
Infection sites for all patients are shown in Figure 1 . Twentyone patients (65.6%) had primary pulmonary infections, 4 patients (12.5%) had primary cutaneous infections, and 4 patients (12.5%) had blood infections and disseminated diseases. Three patients (9.4%) showed evidence of CNS disease. Early presentations of pulmonary infection were noted as multiple patchy shadows with a hole-forming tendency ( Figure 2 ). Cerebral presentation was noted as a polycystic cavity abscess (Figure 3) .
The clinical disease pattern was associated with the patients' immune status (Figure 4 ). Of 4 patients with primary cutaneous disease, 3 were immunocompromised (history of active malignancy and autoimmune hepatitis on prednisolone and azathioprine). Of the 21 patients with pulmonary disease, 14 were immunocompromised. All 4 patients with blood infections and disseminated diseases and 3 of 4 patients with CNS infections were immunocompromised.
Microbiology and antimicrobial susceptibility profiles
Samples collected from 32 patients included sputum, bronchoalveolar lavage fluid, abscess puncture fluid, blood, and skin, brain, and lung tissue samples ( Table 2 ). N. brasiliensis was isolated from 8 patients (25.0%), N. asteroides from 7 patients (21.9%), and N. farcinica from 1 patient (3.1%); Nocardia samples isolated from the remaining 16 patients (50.0%) were unclassified owing to the lack of a typical biochemical reaction or poor emulsification. Drug sensitivity tests indicated that isolates from only 3 patients were resistant to TMP-SMX, of which 1 was an isolate of N. brasiliensis and 2 were unclassified Nocardia spp.; these isolates were all sensitive to amikacin, ceftriaxone, and imipenem.
Treatment and outcome
Among the 32 patients with confirmed nocardiosis, 12 were treated with ceftriaxone or amoxicillin clavulanate potassium combined with amikacin (3 were drugresistant, and 9 could not tolerate TMP-SMX). The other 20 patients were treated with TMP-SMX-based therapy for 6-12 months (average duration: 6.3 months). The prognosis of patients with nocardiosis was generally good. There were 9 deaths (28.1%) in total: 1 case of old age combined with diabetes mellitus, 3 cases of bloodstream infection disseminated to the entire body with long-term application of high-dose glucocorticoids, and 5 cases of severe pulmonary infection combined with destruction of the lung structure.
Discussion
As Nocardia is an opportunistic pathogen, most patients with Nocardia infections are immunocompromised owing to an active malignancy or owing to hormone and immunosuppressant use. The overall proportion of immunocompromised hosts in our study (71.9%) was higher than that in a previous review of Nocardia infections (13) . Patients with systemic disseminated infection accounted for 12.5% of our cases, which was lower than the proportion reported in highly immunosuppressed populations (20%-21%) such as solid-organ transplant patients (14) , possibly owing to our smaller sample size. In this study, patients aged between 18 and 65 years accounted for 84.4% (27/32) of all cases, of whom 33.3% (9/27) were immunocompetent. All patients aged >65 years were free from immunosuppressant therapy and did not have underlying diseases, likely owing to an agerelated reduction in CD4 cell count and function (15) . In addition, our results suggest higher morbidity in women than in men, contrary to the findings of previous studies (16) , possibly owing to 45.0% of our female patients having immunological diseases.
Human Nocardia infection can be caused by inhalation (pulmonary nocardiosis: pneumonia, lung abscess, and cavitary lesions) or bacterial contact through a cut or abraded skin (cutaneous nocardiosis: cellulitis and ulcers), and the infection can then disseminate to the brain, kidneys, joints, heart, eyes, and bones (17) (18) (19) (20) . In our study, pulmonary infection was most common (65.6% of all cases [21/32]), followed by skin infection and bloodstream infection with multiorgan systemic dissemination. Pulmonary infection with Nocardia spp. presented clinical symptoms similar to pulmonary tuberculosis (fever, cough, chest pain, night sweats, weight loss, and pneumonia) (21) . In addition, pulmonary nocardiosis has various imaging manifestations, including pulmonary consolidation, presence of nodules and masses, pleural effusion, and extension of lung infection towards the chest wall resulting in an abscess (22) , which makes clinical diagnosis challenging, delays treatment, and increases the mortality rate. Therefore, laboratory tests including biopsy samples are highly necessary.
Nocardia spp. are associated with human infections and include the N. asteroides complex (more than 50% human cases), N. brasiliensis, N. abscessus, N. cyriacigeorgica, N. (23, 24) . Pulmonary infection is usually caused by N. asteroides, while skin infection and subcutaneous abscesses are mostly caused by N. brasiliensis. Nocardia identification is more rapid and precise when using polymerase chain reaction and 16S RNA sequencing than when using conventional phenotypic methods that study microscopic, cultural, and biochemical properties (25, 26) . However, owing to limited laboratory resources, 16S RNA sequencing was not utilized in this study. Therefore, Nocardia spp. was not classified in 50.00% of cases, which is a limitation of this study. Previously, TMP-SMX was considered the primary therapeutic option for nocardiosis; however, antimicrobial susceptibility studies of Nocardia isolates performed in the USA, Canada, Spain, and Taiwan have revealed TMP-SMX resistance among 2% to 43% of cases (27) (28) (29) (30) (31) . In our study, the TMP-SMX resistance rate was 9.4%, and all isolates were susceptible to amikacin, ceftriaxone, and imipenem.
Clinically, an increase has been observed in Nocardia infection owing to the application of immunosuppressant and antineoplastic drugs. However, owing to a lack of specific clinical manifestations and limited laboratory resources, the diagnosis of Nocardia infection is often difficult or delayed, greatly affecting patient prognosis. Therefore, a clear understanding of epidemiological and clinical data of Nocardia infections in a local region can greatly contribute to the rapid diagnosis of Nocardia infection.
